Cargando…
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective
When an innovative product (innovator) is not covered anymore by intellectual property rights, cheaper equivalent medicinal products (generic products) may be marketed and used in clinical practice. The regulation of generic products is well-established, and is primarily based on standard rules for...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Scientia Pharmaceutica
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475802/ https://www.ncbi.nlm.nih.gov/pubmed/26171329 http://dx.doi.org/10.3797/scipharm.1312-10 |